The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery Meeting Abstract


Authors: Suntharalingam, M.; Winter, K.; Ilson, D. H.; Dicker, A.; Kachnic, L. A.; Konski, A. A.; Chakravarthy, B.; Gaffney, D. K.; Thakrar, H. V.; Horiba, M. N.; Deutsch, M.; Kavadi, V.; Raben, A.; Roof, K. S.; Videtic, G. M. M.; Pollock, J.; Safran, H.; Crane, C. H.
Abstract Title: The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery
Meeting Title: 2014 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 3 Suppl.
Meeting Dates: 2014 Jan 16-18
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-01-01
Language: English
ACCESSION: WOS:000333682100002
PROVIDER: wos
DOI: 10.1200/jco.2014.32.3_suppl.lba6
Notes: Meeting Abstract: LBA6 -- Gastrointestinal Cancers Symposium -- JAN 16-18, 2014 -- San Francisco, CA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David H Ilson
    433 Ilson